Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 30% ± 9% | |
macrophage | 8 studies | 33% ± 7% | |
glutamatergic neuron | 7 studies | 36% ± 18% | |
fibroblast | 7 studies | 29% ± 13% | |
pericyte | 7 studies | 24% ± 5% | |
oligodendrocyte | 7 studies | 25% ± 11% | |
GABAergic neuron | 6 studies | 35% ± 18% | |
microglial cell | 6 studies | 26% ± 11% | |
adipocyte | 6 studies | 31% ± 8% | |
interneuron | 5 studies | 38% ± 17% | |
oligodendrocyte precursor cell | 5 studies | 21% ± 4% | |
dendritic cell | 5 studies | 20% ± 4% | |
smooth muscle cell | 5 studies | 27% ± 11% | |
neuron | 4 studies | 27% ± 12% | |
myeloid cell | 4 studies | 27% ± 7% | |
retina horizontal cell | 3 studies | 22% ± 4% | |
alveolar macrophage | 3 studies | 24% ± 4% | |
monocyte | 3 studies | 21% ± 3% | |
astrocyte | 3 studies | 40% ± 18% | |
granule cell | 3 studies | 28% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 383.99 | 1445 / 1445 | 93% | 2.55 | 171 / 183 |
breast | 100% | 331.42 | 459 / 459 | 91% | 3.25 | 1018 / 1118 |
uterus | 100% | 373.75 | 170 / 170 | 85% | 2.46 | 392 / 459 |
stomach | 98% | 180.43 | 352 / 359 | 81% | 1.47 | 232 / 286 |
intestine | 100% | 233.09 | 963 / 966 | 78% | 1.35 | 411 / 527 |
bladder | 100% | 265.57 | 21 / 21 | 73% | 1.38 | 366 / 504 |
lung | 99% | 267.17 | 573 / 578 | 67% | 1.40 | 769 / 1155 |
brain | 92% | 221.81 | 2442 / 2642 | 68% | 1.31 | 481 / 705 |
skin | 100% | 1125.60 | 1809 / 1809 | 60% | 1.00 | 282 / 472 |
ovary | 100% | 343.63 | 180 / 180 | 56% | 0.92 | 242 / 430 |
adrenal gland | 100% | 261.64 | 258 / 258 | 53% | 1.03 | 123 / 230 |
prostate | 100% | 378.56 | 245 / 245 | 43% | 0.62 | 217 / 502 |
pancreas | 91% | 131.74 | 298 / 328 | 40% | 0.60 | 72 / 178 |
kidney | 94% | 153.78 | 84 / 89 | 23% | 0.33 | 208 / 901 |
thymus | 100% | 226.38 | 651 / 653 | 14% | 0.31 | 85 / 605 |
spleen | 100% | 306.89 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 300.50 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 300.12 | 800 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 282.27 | 1329 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 3.51 | 44 / 45 |
heart | 95% | 197.79 | 821 / 861 | 0% | 0 | 0 / 0 |
liver | 79% | 110.95 | 179 / 226 | 13% | 0.19 | 52 / 406 |
lymph node | 0% | 0 | 0 / 0 | 76% | 1.84 | 22 / 29 |
peripheral blood | 49% | 182.76 | 454 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 16% | 0.19 | 13 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034080 | Biological process | CENP-A containing chromatin assembly |
GO_0007059 | Biological process | chromosome segregation |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000939 | Cellular component | inner kinetochore |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | CENPP |
Protein name | Centromere protein P (HCG1643604) Centromere protein P (CENP-P) |
Synonyms | hCG_1643604 |
Description | FUNCTION: Component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex. . |
Accessions | ENST00000375576.1 ENST00000375579.7 [Q6IPU0-2] X6R9C8 ENST00000707234.1 [Q6IPU0-2] ENST00000375587.8 [Q6IPU0-1] ENST00000707232.1 [Q6IPU0-1] Q6IPU0 |